Skip to main content
Top

Drugs

Issue 3/2020

Content (9 Articles)

Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy

Alexander C. Cohen, Brandon M. Roane, Charles A. Leath III

In Search of the Long-Desired ‘Copernican Therapeutic Revolution’ in Small-Cell Lung Cancer

Noemí Reguart, Elba Marin, Jordi Remon, Roxana Reyes, Cristina Teixido

Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent

George G. Zhanel, Jenine Esquivel, Sheryl Zelenitsky, Courtney K. Lawrence, Heather J. Adam, Alyssa Golden, Rachel Hink, Liam Berry, Frank Schweizer, Michael A. Zhanel, Denice Bay, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Joseph P. Lynch III, James A. Karlowsky

Ubrogepant: First Approval

  • Open Access
  • Migraine
  • AdisInsight Report

Lesley J. Scott

Golodirsen: First Approval

Young-A Heo

Givosiran: First Approval

Lesley J. Scott

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images